BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17566854)

  • 1. Organotropism of breast cancer metastasis.
    Lu X; Kang Y
    J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):153-62. PubMed ID: 17566854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer lung metastasis: Molecular biology and therapeutic implications.
    Jin L; Han B; Siegel E; Cui Y; Giuliano A; Cui X
    Cancer Biol Ther; 2018; 19(10):858-868. PubMed ID: 29580128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
    Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
    Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.
    Yousefi M; Nosrati R; Salmaninejad A; Dehghani S; Shahryari A; Saberi A
    Cell Oncol (Dordr); 2018 Apr; 41(2):123-140. PubMed ID: 29568985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
    Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting RANKL in breast cancer: bone metastasis and beyond.
    Azim H; Azim HA
    Expert Rev Anticancer Ther; 2013 Feb; 13(2):195-201. PubMed ID: 23406560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From breast to the brain: unraveling the puzzle of metastasis organotropism.
    Hu G; Kang Y; Wang XF
    J Mol Cell Biol; 2009 Oct; 1(1):3-5. PubMed ID: 19633017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone.
    Guiu M; Arenas EJ; Gawrzak S; Pavlovic M; Gomis RR
    Methods Mol Biol; 2015; 1293():221-9. PubMed ID: 26040691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
    España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
    Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New tricks against an old foe: molecular dissection of metastasis tissue tropism in breast cancer.
    Kang Y
    Breast Dis; 2006-2007; 26():129-38. PubMed ID: 17473371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
    Sheng L; Wu CY; Chen XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):684-9. PubMed ID: 21812275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic targets for cancer bone metastasis.
    Krzeszinski JY; Wan Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of cancer cell metastasis to the bone: a multistep process.
    Patel LR; Camacho DF; Shiozawa Y; Pienta KJ; Taichman RS
    Future Oncol; 2011 Nov; 7(11):1285-97. PubMed ID: 22044203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
    Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
    Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.
    Wang C; Xu K; Wang R; Han X; Tang J; Guan X
    J Exp Clin Cancer Res; 2021 Nov; 40(1):370. PubMed ID: 34801088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in the development of organ-specific metastasis.
    Urabe F; Patil K; Ramm GA; Ochiya T; Soekmadji C
    J Extracell Vesicles; 2021 Jul; 10(9):e12125. PubMed ID: 34295457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
    Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.